Fenwick & West has advised iRhythm Holdings. Goodwin Procter has advised VitalConnect. iRhythm Holdings, Inc. (Nasdaq: IRTC), a digital healthcare company specializing in solutions for disease...
iRhythm to Acquire VitalConnect in $287.5 Million Digital Health Deal
GeneDX’s Acquisition of Fabric Genomics
Fenwick & West represented GeneDX in the transaction, and DLA Piper advised Fabric Genomics, Inc. GeneDX (Nasdaq: WGS), a company delivering improved health outcomes through genomic...
Standard BioTools’ Merger with SomaLogic
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
Paragraf’s Acquisition of Cardea Bio
Fenwick advised Paragraf on the deal. Paragraf, a producer graphene electronics using transfer-free graphene and standard semiconductor processes, announced its acquisition of Cardea Bio, a producer of...




























